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Introduction
Rationale 
In the United States (US), botanical dietary supplements are 
regulated by the Food and Drug Administration under the 1994 
Dietary Supplement Health and Education Act. The Act defines dietary 
supplements as “a product (other than tobacco) that is intended to 
supplement the diet that bears or contains one or more of the following 
dietary ingredients: an herb or other botanical, a vitamin, a mineral, 
an amino acid, a dietary substance for use by man to supplement the 
diet by increasing the total daily intake, or a concentrate, metabolite, 
constituent, extract, or combinations of these ingredients” [1].
Botanical supplements are popular in the US; national surveys 
estimate that approximately 18% of the US population uses botanical 
supplements [2,3]. The literature supports a wide body of prevalence 
data on botanical supplement use in the general population, but 
less is known about use patterns in minority populations, including 
Hispanics/Latinos [3-6]. Among studies in these populations, 
prevalence estimates vary widely and the reasons for these large 
variations are obscure. Due to the increasing population of Hispanic/
Latino patients and the biological activity of botanical supplements, it is 
important that health care and public health professionals understand 
their likelihood of botanical use. 
Hispanic/Latino populations encompass people from diverse 
cultural traditions with differences in dialects, primary language, 
and traditions [7]. In some Hispanic/Latino populations, attitudes 
and beliefs about the use of botanical medicines are part of a cultural 
belief system transmitted through female relatives [7-11]. Surveys 
and interviews with Hispanic/Latino immigrants report a belief that 
botanical remedies are safer than prescription drugs and consistent 
with family traditions [11,12]. Medications are not eschewed, however; 
herbal teas are often consumed along with medications, especially 
among diabetics [8,13]. In fact, conventional medical care and 
physician’s advice may be highly valued [14]. However, herbal remedies 
may be chosen both because they are consistent with cultural practices 
and are cheaper and easier to obtain; one study, annual income was 
the strongest predictor of alternative medicine use (chiefly botanicals) 
[14]. In other studies, especially in areas of the country far from the 
Abstract
Background: The prevalence of botanical supplement use among Hispanics/Latinos in the United States varies widely, 
thwarting efforts to understand patterns of use in these rapidly growing populations. In this systematic review of the literature, 
we present an analysis of patterns of botanical supplement use across available studies including Hispanics/Latinos in the 
United States, 1998-2011. 
Methods: Search strategies included CINAHL, EMBASE, Global Health, CAB Abstracts, AMED and Medline resulting 
in 33 studies reporting botanical supplement prevalence among Hispanic/Latino adults, limiting studies to those with similar 
outcomes and Hispanic/Latino sample ≥1%. 
Results: Median prevalence of botanical supplement use among Hispanics/Latinos varied from 12% for ≤30 days of use 
to 27% for 6-12 months of use and 45% for 2+ years of use. Variation in prevalence of botanical use among Hispanics/Latinos 
was largely dependent on study design factors, particularly sampling strategy and target population. Patterns associated with 
higher median prevalence included regional (42%, 95% CI: 35, 57%) vs. national (15%; 8, 22%) samples, convenience (45%; 
35, 63%) vs. probability sampling (21%; 10, 42%), and majority Hispanic/Latino (45%; 32, 67%) vs. majority non-Hispanic/
Latino (21%; 15, 42%) samples. Studies targeting Hispanic/Latino populations with botanical assessments specific to these 
populations resulted in higher prevalence estimates (49% vs. 18%). The most common botanicals reported by Hispanics/
Latinos across studies were chamomile, aloe, and garlic.
Conclusions: Although studies with probability sampling are less affected by selection bias, most target the general US 
population and exclude botanical supplements common among Hispanic/Latino populations. Improved estimates of botanical 
supplement use among Hispanics/Latinos require culturally-relevant assessment instruments and strategies. Assessments 
of botanical supplement use in other ethnic populations, e.g., among immigrants from Asian countries, are also likely to suffer 
from information bias.
Ep
id
em
iolo
gy: OpenAccess
ISSN: 2161-1165
Citation: Faurot KR, Filipelli AC, Poole C, Gardiner PM (2015) Patterns of Variation in Botanical Supplement Use among Hispanics and Latinos in the 
United States. Epidemiol 5: 195. doi:10.4172/2161-1165.1000195
Page 2 of 9
Volume 5 • Issue 3 • 1000195
Epidemiol
ISSN: 2161-1165 Epidemiol, an open access journal
US-Mexican border, botanical use may be less common because it is 
less available.
Unlike in the general population, factors related to botanical 
supplement use among Hispanics/Latinos are incompletely understood. 
Education appears either to play a limited role or a role that varies 
across degrees of acculturation [15,16]. Moreover, the operational 
definition of acculturation itself is variable. Most studies including 
acculturation as a covariate limit its definition to length of residence in 
the US and/or primary language [17,18], the latter possibly conflated 
with employment opportunity and income rather than Hispanic/Latino 
identity [14]. Some studies report higher prevalence estimates among 
recent immigrants [19-22], but others find no association between 
length of residence and the prevalence of botanical supplement use 
[14,17,23,24]. Moreover, a closer examination of the studies suggests 
that overall prevalence may not differ much by acculturation, regardless 
of its measurement, but by the types of botanicals used. 
Objectives
The objective of this systematic review was to examine patterns 
in the prevalence of botanical supplement use among US Hispanics/
Latinos through a comprehensive examination of the biomedical 
literature. Specifically, we wished to answer the question: What study-
related characteristics could be associated with higher prevalence 
estimates? A secondary objective was to quantify disclosure rates of 
botanical supplement use to health care providers within our sample 
of studies as well as to examine patterns in studies associated with 
those rates. Finally, because the specific botanical supplements used 
in Hispanic and Latino populations were reportedly different from the 
general population, we wished to document those differences.
Materials and Methods 
Information sources 
The senior author developed the study protocol, including 
the strategy for study identification: electronic database searches 
(CINAHL, EMBASE, Global Health, CAB Abstracts, AMED, and 
Medline) with keywords: herbal, herb, medicinal plant, botanical, 
dietary supplement, and Hispanic or Latino along with a manual 
search of retrieved references (Figure 1). The search included only 
citations published in the biomedical literature from 1998 until 2011, 
excluding dissertations, meeting abstracts, non-English publications, 
and studies outside the United States. The following studies met the 
protocol’s eligibility criteria: 
•	 Adult populations (age 18 and older);
•	 Adequate Hispanic/Latino sample, defined as n ≥10 and 
proportion ≥ 0.01;
•	 All quantitative data collection methods accepted (face-to-
face, telephone, and self-administered written questionnaires);
•	 Prevalence reported for botanical supplement use.
Data collection process
Two authors reviewed abstracts resulting from electronic database 
searches and identified studies meeting eligibility requirements. The 
two extracted information systematically with entry into a database 
file. A third author adjudicated any disagreements in data extraction. 
Outcomes collected included the following: 1) study sampling 
techniques (probability vs. convenience); 2) data source; 3) year of 
publication; 4) publication journal; 5) data collection type (face-to-
face interview, telephone interview, written survey); 6) language of 
study instruments (English, or English plus Spanish); 7) time period 
of the recall (e.g., use over the past 1-2 weeks, month, etc.); 8) location 
of study in the US (national, Mexican border, southeast, Midwest); 9) 
definition of botanical supplements in study (e.g., “herbal remedies” 
vs. “non-vitamin, non-mineral dietary supplements” vs. “biologically-
based therapies”); 10) sample population characteristics (age and 
gender distributions, education, insurance, US born, years in the US, 
and, where applicable, health conditions represented); 11) study size, 
including the size of the Hispanic/Latino sample population; 12) and 
commonly reported botanicals. In addition, the authors captured 
disclosure of botanical supplement use to health care providers. 
 To examine the impact of sample characteristics across studies, 
we limited the analysis to studies including a prevalence estimate of 
botanical supplement use among Hispanics/Latinos where Hispanics/
Latinos made up at least 1% of the sample with a sub-sample size of 
≥10. Of the studies using the same dataset, we chose the study with 
the largest sample size. For example, if the study was based on the 
2002 National Health Interview Survey (NHIS) sample, we used the 
report with estimates for the entire population rather than estimates 
for subgroups, such as older adults or patients with diabetes. We 
included only studies with a reasonably similar outcome, defining the 
prevalence of herb use, herbal medicine, herbal therapy, or “herbal 
and home remedies”. We excluded qualitative studies and those in 
which botanical supplement use for specific conditions was reported 
(rather than botanical supplement use among those with a particular 
condition).
Sources of bias 
We evaluated sources of bias within studies, including recall bias, 
selection bias, and information bias, but made no attempt to restrict 
the sample of studies by any definition of study quality. To assess recall 
bias, we considered the recall period and target population (patients 
vs. general public). To evaluate selection bias, we examined the study 
sampling strategy, response rate, and target population. Finally, to 
gauge information bias, we considered the study instrument, both in 
terms of language and the specific botanicals included. 
Summary measures and synthesis of results
Summary measures were limited to presentation of median 
Figure 1: Sample database search for systematic review of the prevalence of 
botanical supplement use among Hispanics and Latinos in the United States 
1998-2011. The search of Medline/PubMed is presented.  The original search 
was undertaken in 2011, but was updated 5/4/2012.
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prevalence statistics along with nonparametric bivariate tests (Mann 
Whitney U, Kruskal-Wallis). We calculated the median prevalence of 
botanical use (%) along with its binomial-based confidence interval for 
each stratum. Medians are reported to limit the influence of outliers. 
All analyses were conducted using Stata software Version 12 (Stata 
Corp LP, College Station, Texas 77845-4512). Stata employs confidence 
interval calculation methods based on a binomial distribution as 
described in Mood and Graybill [25].
To assess prevalence across studies controlling for recall, we stratified 
by the study instrument recall period: use over 1-2 weeks, 6 months 
to 1 year, and 2 or more years (including lifetime use). To examine 
sources of selection bias, we compared prevalence estimates according 
to the study’s sampling strategy (convenience vs. probability), the size 
of the study, and the proportion of Hispanics/Latinos in the sample. 
We also examined the target age (designed for older adults ≥65 years 
old vs. <65), the gender distribution (percent male) and the population 
target (patients vs. general population). Education and insurance data 
definitions varied too much to include in our analysis. We examined 
the influence of both the primary language of the study—categorized 
as English and Spanish vs. English alone and the representativeness of 
the study—regional vs. national. We classified type of publication as a 
complementary and alternative medicine (CAM) journal or a general 
biomedical journal. We examined the relationships among the study 
variables using a Spearman correlation procedure. Due to its public 
health and clinical relevance, we also captured disclosure of botanical 
supplement use to health care professionals among the studies we 
assessed. Finally, we examined the specific botanical supplements 
reported by Hispanics/Latinos across the studies qualifying for the 
review. We extracted the 10 most prevalent botanical supplements 
reported in each study and documented the number of studies in which 
they were reported.
Results
Study selection 
Figure 2 portrays the search and selection process. After excluding 
studies without the appropriate population, language or outcome, 
121 studies remained for more complete review. A review of study 
references yielded an additional 27. Six studies were excluded because 
of inadequate Hispanic/Latino sample size and another 9 studies lacked 
prevalence for Hispanics/Latinos. Twenty-three studies were excluded 
due to a duplicate data source. Of the remaining studies, 18 were 
qualitative, 15 reported the use of botanicals for treatment of a specific 
illness, and 22 reported the prevalence of all dietary supplements 
combined (Web Table 6). An additional 22 studies did not meet criteria 
for other reasons. References for and descriptions of excluded studies 
are provided in the Appendix. 
Study descriptions
Thirty-three studies of botanical use prevalence among Hispanics/
Latinos constituted the analysis sample, including studies inquiring 
about current botanical use—within the past 30 days or less — Table 1 
[22,26-29], within the past 6-12 months — Tables 2a and 2b [6,24,29-
45], and use within 2 or more years — Table 3 [4,21,23,46-52]. Tables 
present data on study type (regional vs. national), sampling strategy 
(convenience vs. probability), target population, sample size (total and 
Hispanic/Latino), prevalence of botanical supplement use, botanical 
definitions, other variables collected in the study, study response rate, 
rate of disclosure of use of botanical supplements to physicians, and 
sample age range. Across the 32 studies, the total number of Hispanics/
Latinos was 18,316 with a total N across studies of 96,523. Study size 
ranged from 30 to 29,990 with Hispanic/Latino sample sizes of 11 to 
3,599. More than half (53%) of the studies reported at least 500 subjects. 
Two-thirds of the studies included non-Hispanics, about half had a 
minority Hispanic/Latino sample, and 12% included fewer than 50 
Figure 2: Search and selection process.
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Hispanics/Latinos. Half of the studies were conducted within patient 
populations. Studies among patients included those with cancer [47], 
HIV [45], menopause [50], surgical patients [29,46], and pregnancy [42] 
as well as patients attending primary care clinics [21,23,24,41,51,52]. 
Regional studies included those from states along the Mexican border 
(Texas, New Mexico, Arizona, California: 50%) as well as in other 
parts of the country (Florida, New York, Massachusetts, Illinois: 
28%). About a fourth of the study samples were representative of the 
national population. Twenty-two percent of studies were published in 
complementary and alternative medicine journals with the remainder 
in general biomedical journals. Information on exposures pertinent 
to prevalence estimates varied among studies: 59% collected data 
on income, 38% insurance, and 41% collected data on acculturation 
(birthplace or duration of US residence). The vast majority of studies 
(91%) collected education status, but categorization was inconsistent. 
Botanical supplement prevalence estimates among Hispanics/Latinos 
ranged from 4.7 to 80%.
Twenty-two studies reported a response rate. Of those, 23% 
reported a response rate less than 70%. Probability sampling was 
employed by only 41% of the studies. More than 40% of studies were 
available only in English and 34% of studies used data instruments 
directed to the general public, excluding botanicals common among 
Hispanics/Latinos, including specific questions about botanical teas. 
Summary prevalence estimates
Table 4 presents prevalence estimates for studies of botanical 
supplement use across a number of study variables. As expected, 
median prevalence estimates were higher for assessment periods of 
First author, Year, 
Journal
Study type, sampling strategy, target 
population
N (H-L/Total) 
Prevalence (H-L/
Total)
Botanical- related outcomes
Response 
rate 
disclosurea
Age mean (SD), 
min-max 
Kelly, 2006, J Alternative 
Complement Med [26]
National survey (Slone), probability, US 
adults
1,109/13,436 
 
15%/17%
Use of herbal/natural supplements in the 
past week 68% nr 18+24% >65
Loera, 2001, J 
Gerontology [22]
National cohort study (EPESE), 
probability, Older Mexican Am. in 
southwestern US
2734 10% Use of folk medicine, herbs, herbal remedy over prior 2 weeks 83% nr 65+70% <75
Ness, 2005, 
Gerontologist [27]
National survey (Health and Retirement 
Study), probability, Older adults 77/1099 12%/19% Current regular use of herbal supplements 79% nr nr 65+
Raji, 2005, Annals 
Pharmacother [28]
Regional cohort: HPS (TX), probability, 
Older adults (>76) 128/365 5%/6%
Use of herbal supplements in the past two 
weeks 61% nr 77+ majority>80
Rivera, 2005, Am 
Surgeon [29]
Regional survey (TX), probability, 
Mexican-American surgical patients
115/115; 12 month: 
62%; 30 days: 43%
Use of herbal products past 12 months & 
30 days 7.6% nr 48.6 19-81
Abbreviations: H-L: Hispanic or Latino; nr: not reported; a. Disclosure of use of botanical supplements to health care providers.
Table 1: Studies assessing botanical supplement use in the past 7-30 days among US Hispanics/Latinos 1998-2011.
First author, Year, 
Journal
Study type, Sampling strategy, 
Target population
N (H-L/Total) 
Prevalence (H-L/Total) Botanical outcomes
Response Rate 
Disclosurea (H-L/Total)
Age mean 
(SD), min-max
Bair, 2008, Menopause [30] National cohort: SWAN, probability, middle-aged women 283/3295 9%/18%
Herbal remedy use in the past 
12 months 70% complete data, nr 45.7, 42-52
Burge, 2002, Am J Pub 
Health [31]
Regional survey (TX), convenience, 
family practice patients
460/575 27%/24% + 
15%/14% used home 
remedies
Herbal remedy use in the past 
12 months 78%, nr/43% 43.8
Cherniack, 2004, Alt Comp 
Therap [32]
Regional survey (NY), convenience, 
Primary care patients ≥60 27/209 37%/32%
Use of herbs in the past 12 
months nr 74.7
Fennell, 2004, Preventive 
Med [33]
National survey: NHIS 2000, 
probability, US population 2,901/24,834 7%/15%
Use of any mixed or single 
herb or botanical in the past 
12 months
72% N nr/24% 18+ 42% <40
Gordon,2005, BMC 
Geriatrics [34]
Regional survey (CA), probability, 
Older women in Northern CA 147/3,109 21%/25%
Use of any herbal supplement 
past 12 months 72% nr 65-84
Graham, 2005, J Nat Med 
Assoc [35]
National survey: NHIS 2002, 
probability, US population 3,599/29,990 17%/19%
Use of herbal medicine in past 
12 months 73% 31%/40% 18+
Keegan, 2000, J Holistic 
Nursing [36]
Regional survey (TX), convenience, 
general public (grocery store) 60/120 52%/32%
Use of herbal medicine in past 
12 months nr 55%/27% 80+% under 50
Kronenberg, 2006, Am J 
Public Health [37] Loera, 
2007, Complement Ther 
Clin Pract [38]
National survey of CAM use, 
probability, US adult women 1,057/3,921 18%/15%
Use of medicinal herbs and 
teas in the past year 79% (69% H-L) nr
18-50+ 83% of 
Hisp <50
Loera, 2007, Complement 
Ther Clin Pract [38]
National cohort study (EPESE), 
probability, Older Mexican Am. in 
southwestern US
1445 28% Use of CAM/herbal medicine in the past 12 months
83% (1/2 sample 
censored) nr 71 (5.2)
Mackenzie, 2003, Alt Ther 
Health Med [39]
National survey (National Comparative 
Minor Health Care Survey), 
probability, US population
581/3452 23%/19% Use of herbal medicine over the past 12 months 60% nr
Ortiz, 2006, J Am Pharm 
Assoc [40]
Regional survey (FL), convenience, 
Hispanics in South Florida 142 74%
Use of herbal supplements in 
past 12 months 71% nr 39 18-65+
Abbreviations: H-L: Hispanic or Latino; nr: not reported; NHIS: National Health Interview Survey; EPESE: Established populations for the Epidemiologic Study of the 
Elderly. a. Disclosure of use of botanical supplements to health care providers.
Table 2a: Studies assessing botanical supplement use in the past 12 months among US Hispanics/Latinos.
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6-12 months (27%) or 2 years or more (45%) as compared with ≤ 30 
days (12%); many botanical supplements are consumed intermittently. 
Median prevalence estimates were higher in convenience (45%) 
vs. probability (21%) samples (Figure 3). In addition, regional 
studies reported higher prevalence estimates (42%) than nationally 
representative samples (15%). Sample characteristics associated with 
higher median prevalence of botanical use among Hispanics/Latinos 
included studies with: 1) patient populations (46 vs. 18%); 2) a focus on 
younger vs. older adults (42 vs. 12%); and 3) majority male vs. majority 
female samples (42 vs. 31%).
Studies with a majority Hispanic/Latino sample population 
reported a median prevalence of 45% (vs. 21%). Studies including 
botanicals common in Hispanic/Latino populations, such as botanical 
teas, reported higher median prevalence estimates than those focusing 
on botanical supplements common in the general population (49% vs. 
18%). Studies conducted only in English yielded a median prevalence 
of 18% while those conducted in Spanish and English had a median 
prevalence of 42%.
Variability in the estimates was high with wide binomial confidence 
intervals around the medians. In addition, because of considerable 
overlap in the categories and the small number of studies considered, 
the independent contributions of study and sample characteristics 
could not be determined. For example, studies with probability samples 
were likely to be designed for the national population, in English, with 
a minority Hispanic/Latino population, and inquiries about botanicals 
common to the general population, whereas convenience samples 
First author, Year, Journal Study type, Sampling strategy, Target population
N (H-L/Total) 
Prevalence (H-L/Total) Botanical outcomes
Response Rate 
Disclosurea (H-L/Total)
Age mean (SD), 
min-max
White, 2009, J Am Board Family 
Medicine [24]
Regional survey (CA), 
convenience, Low-income 
Hispanic/Latino clinic patients
164 63%
Use of herbal/tea/plant-based 
substances in the past 12 
months
100% nr nr
Zeilmann, 2003, Pharmacother 
[41]
Regional survey (NM), 
convenience, Geriatric clinic 
patients
84/186 61%/49% Use of herbal medicine in the past year >95% 28%/26% 65->85 
Bercaw, 2010, Birth Issues 
Perinatal Care [42]
Regional survey (TX), 
convenience, Hispanic 
women, childbearing age
485 19% Herb use during pregnancy 90%, 66% 26.8 18-42
Ma, 2011, BMC Cancer [43]
Regional cohort study (CA), 
probability, Female breast 
cancer survivors <40
36/371 50%/59%
Use of any of a list of herbal 
remedies in the past six 
months
50% At diagnosis: <35 to 40
Tsang, 2007, Top Clin Nutrition 
[6]
Regional survey (MA), 
convenience, Physically active 
adult members of ethnic 
minorities
11/106 18%/27% Botanical supplement use in the past 6 months nr 85% 18-65. 54% <35
Abbreviations: H-L: Hispanic or Latino; nr: not reported; aDisclosure of use of botanical supplements to health care providers.
Table 2b: Studies assessing botanical supplement use in the past 6-12 months among US Hispanics/Latinos.
First author, Year, Journal Study type, Sampling strategy, Target population
N (H-L/Total) 
Prevalence (H-L/Total) Botanical- related outcomes
Response Rate 
Disclosurea 
Age mean 
(SD), min-max
Adusumilli, 2008, Holistic 
Nursing [46]
Regional survey (NY), 
Convenience, Patients presenting 
for surgery
270 / 2,186 37% / 38% Herbal medicine use in 2 years before surgery 65% nr/7% 18+ 
Greenlee, 2009, Breast Cancer 
Res Treat [47]
Regional cohort baseline (CA), 
probability, Insured women with 
breast cancer
102/1,000 42%/47% Use of botanical supplements over five years since diagnosis 51%nr 50-75
Howell, 2006, J Am Family 
Medicine [21]
Regional survey (IN), convenience, 
Hispanic family medicine patients 620 80% Use of herbal remedies ever nr 26% 
<20 to ≥ 40 
(14% ≥ 40) 
Jernewall, 2005, AIDS Care [48]
Regional survey (NY, DC), 
convenience, HIV positive gay or 
bisexual H-L men
152 42% Use of plant-based CAM (herbs, home remedies) ever nr nr 39 29-69
Kuo, 2004BMC Complement 
Altern Med [23]
Regional survey (TX), convenience, 
urban primary care patients 30/98 50%/36%
Use (ever) of herbs or herbal 
products or natural medicines 98% nr 
<30 to >50 
48% of Hisp 
>50 
Lundy, 2001, Complement 
Health Pract Review [49]
Regional survey (AZ), 
convenience, Low-income patients 
at family practice centers
386/516 35%/25% Use of special herbs over the past two years 83% 36%
33 (14) Hisp 
43 (18) NHW
Mahady, 2003, Menopause [50]
Regional survey (IL), convenience, 
Middle-aged women (40-60) 
attending clinics
59/500 75%/79% Use of botanical supplement use, including herbal teas (ever) 75% 30% 50.3 40-60
Mikhail, 2004, J Altern 
Complement Med [49]
Regional survey, convenience, mix 
of Hispanic/Latino primary care 
patients and general population
179/179 36%/36% Use of herbs to treat disease 100% 21% 49 (16)
Trangmar, 2008, Annals Family 
Medicine [51]
Regional survey (SC), 
convenience, family practice 
patients
70 67% Use of herbal medicines or teas ever nr nr 76% under 50
Zenk, 2001, Health Care 
Women Int [4]
Regional survey (IL), convenience, 
Middle-aged Mexican American 
women
30 47%
Use of herbal or natural 
remedies to help with symptoms 
or your health during midlife
nr nr 40-56
Table 3: Studies assessing botanical supplement use in the past 2+ years among US Hispanics/Latinos.
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were more often conducted in a regional locale with study instruments 
designed for the local population. 
Disclosure to Health Care Providers
Eight of the included studies provided information on disclosure 
of botanical supplement use to health care providers for the Hispanics/
Latinos and non-Hispanics and 10 studies reported disclosure rates 
specifically for Hispanics/Latinos. For Hispanics/Latinos, disclosure 
rates ranged from 8 to 66% with a mean of 31% and median of 30. 
For studies including Hispanic/Latino and non-Hispanics, disclosure 
rates ranged from 7 to 53% with a mean of 34 and median of 37. 
Interestingly, differences in disclosure rates between studies among 
patients and those in non-patient populations were not large: median 
32% (95% CI: 14, 48) vs. 40% (95% CI: 17, 40). Studies that asked 
about disclosure of other complementary therapies (e.g., acupuncture, 
massage, meditation) in addition to botanicals reported higher rates of 
disclosure to physicians (37%; 95% CI: 24, 50), compared with studies 
that focused solely on botanicals (23% ; 95% CI: 7.1, 33) (p=0.15).
Common botanical supplements among Hispanics/Latinos
Ten of the studies reported the most common botanical supplements 
among Hispanics/Latinos (Table 5). These included chamomile, aloe, 
mint, and garlic [14,21,29,40,45,49]. It should be noted that, unlike 
consumption of botanical supplements in the general population, these 
botanicals are often consumed in teas or other raw forms. Note that 
other botanicals on the list are unusual in the general population as 
well, e.g., lime tree (linden), prickly pear cactus (nopal), and corn silk.
Discussion 
This unique comprehensive systematic review explores study 
characteristics associated with variations in the prevalence of botanical 
supplement use among Hispanics/Latinos. As we expected, we noted 
differences in prevalence related to the proportion of Hispanics/
Latinos in the sample population, the sampling strategy, and sample 
characteristics. In regional samples, potentially biased by the sampling 
strategy, prevalence estimates were almost three times as high as in 
nationally-representative population surveys. However, in nationally-
representative samples, ethnic minorities, especially recent immigrants, 
may be under-represented (40). For example, among studies of 
individuals along the Mexican border over a 6-12 month recall period, 
prevalence estimates of botanical supplement use range from 19 to 78% 
[24,29,31,34,36,38,41,44,45]. In contrast, prevalence estimates among 
Hispanics/Latinos in nationally-representative samples over a similar 
time period ranged from 7 to 23% [30,33,35,37,39]. Not surprisingly, 
because the language used to describe botanicals among Hispanics/
Latinos differs from that of the general US public (including plant 
names, product formulations, and typical use patterns), assessment 
instruments designed for Hispanic/Latino populations produce higher 
prevalence estimates than those created for national samples. In some 
studies, supplement definitions consisted of commercial products 
only [26,35,39]; in others, information on any botanical substance 
(including herbal teas) used to prevent or treat a disease or illness was 
solicited [22,24,29,37,44-45,50,51]. As teas are commonly consumed 
in many Hispanic/Latino populations [52], botanical assessments that 
exclude them may result in serious underestimates. Among the studies 
of botanical supplement use in the past 6-12 months with instruments 
that target botanical supplements common among Hispanics/Latinos, 
prevalence of use among Hispanics/Latinos ranged from 18 to 80 %, 
median 50% [24,29,31,36-38,41,44,45,49] while among those that do 
not target Hispanic/Latino botanical supplements, the range was 7 to 
42%, median 18% [6,30,33-35,39,43]. 
We identified a number of sources of bias in the studies. Studies 
based on national probability samples were either hampered by an 
overall poor response rate [35], did not report a response rate [33], 
or had a differential, lower response rate for Hispanics/Latinos [37]. 
In addition, studies utilizing the NHIS, with data collection by census 
staff, may have excluded certain Hispanic/Latino populations, such 
as recent or undocumented immigrants. Other probability samples 
used sampling frames biased toward individuals with higher incomes. 
For example, an otherwise excellent study limited its sample to older 
 Prevalence of use of botanical supplements
 n N Median 95% CI Pa
Overall 33 96,702 37 21, 49  
Time period
 Over ≤30 days 5 17,749 12 4.7 , 43 0.02
 Over 6-12 months 18 73,378 27 19 , 59  
 Over 2+ years 10 5,575 45 36, 73  
Sample type
 Probability 13 83,011 21 9.9, 42 0.01
 Convenience 20 13,691 45 35, 63  
Data collection method
 Interview 21 74,580 36 18, 56 0.6
 Written 12 22,122 40 19, 52  
Publication type
 CAM journal 8 19, 679 36 20, 51 0.8
 General journal 25 77,023 42 18, 59  
Regional vs. national
 Regional 26 16,675 42 35, 57 0.001
 National 7 80,027 15 7.7, 22  
Sample populationa
 General public 16 88,578 18 11, 37 0.003
 Patients 16 7,945 46 37, 65  
Target age of population
 Adults ≥65 7 9,147 21 6.3, 53 0.07
 Adults <65 26 87,555 42 24, 51  
Gender distribution
 Majority males 5 4,250 42 23, 50 0.5
 Majority females 26 92,168 31 18, 49  
Language of instrument
 Spanish & English 20 16,880 42 29, 63 0.02
 English only 13 79,822 18 9.9, 45  
Sample proportion of H-L
 Majority H-L 16 8,321 45 32, 67 0.02
 Minority H-L 17 88,381 21 15, 42  
Size of H-L sample
 N < 250 18 8,239 45 37, 58 0.08
 N ≥ 250 15 88,463 23 15, 37  
Botanicals common among H-L
 No 11 82,716 18 11, 37 0.003
 Yes 22 13,986 49 35, 63  
Abbreviations: H-L—Hispanics -Latinos; n: number of studies; N: sum of sample 
populations; 
 CI: confidence interval, calculated using binomial method; CAM: 
Complementary and alternative  
medicine. a. p values are based on Kruskal-Wallis (or Mann-Whitney U) rank 
nonparametric tests.  
 All analyses were conducted in Stata 13. a. One study excluded due to including 
both patients and the general public. b. Two studies excluded due to non-report 
of gender distribution.
Table 4: Prevalence of the use of botanical supplements in studies including 
Hispanics/Latinos 1998-2011 across characteristics of included studies.
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women covered by a particular health plan [47]. Similarly, studies that 
utilized telephone surveys excluded those without telephones [39]. 
Studies using cohort follow-up samples [30,38] may have suffered from 
bias due to differential loss to follow up. Many convenience studies 
were likely to have been biased by differential non-response: non-
users of botanical supplement may have been less likely to respond. 
Some of the best studies with convenience samples, with close to 100% 
response rates were difficult to compare, due to differences in their 
target populations. One study was undertaken in a low-income clinic 
[24] and another among patients presenting for surgery [29]. 
Other potential sources of bias included recall and information 
bias. The majority of the studies asked respondents to recall their use 
of botanical supplements over a period of several months. It is unclear 
whether or not respondent characteristics, such as poor health [38] or 
adverse pregnancy outcomes [42] may have affected recall. 
Variable botanical supplement definitions also affected prevalence 
estimates. Although we excluded studies of non-botanical dietary 
supplements from our final analysis, we cannot be certain that questions 
about “herbal products” [44] and “herbal remedies” [31] are the same. 
In the general public, botanical supplement use is more prevalent 
among women and those with chronic conditions [3,53]. National 
studies have also predicted higher use of botanical supplement among 
older Hispanics/Latinos as compared with non-Hispanic whites [54]. 
However, among Hispanics/Latinos in the selected samples, botanical 
supplement use in studies targeting older adults was somewhat lower 
than studies targeting all adults or studies targeting middle-aged 
adults. In our sample of studies, we documented higher prevalence 
among patient populations, but studies with predominantly female 
populations did not have higher prevalence estimates. 
English name Spanish name Number of studies reporting
Garlic Ajo 11
Chamomile Manzanilla 11
Aloe vera Savila 9
Ginseng Ginseng 5
Mints Yerba Buena 5
Oregano Oregano 5
Lime Tree (Linden) Tilo, Flor de Tila 4
Prickly pear cactus Nopal 4
Ginger Jengibre 3
Wormwood Ajenjo 3
Mullein Gordolobo 3
Eucalyptus Eucalipto 3
Cinnamon Canela 3
Star anise Anis estrella 2
Corn silk Pelo de Elote 2
Twelve studies reported at least one botanical used commonly by 
Hispanics/Latinos. Of the studies reporting multiple botanicals, the top ten 
most common were chosen. Of those, only botanicals reported by at least 
two studies are listed.
Table 5: Most common among Hispanic/Latino populations in the United States.
Figure 3: Prevalence of botanical supplement use among Hispanics/Latinos by sample characteristics.
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The language of the study instrument had an impact on estimates. 
Not only did studies offered only in English exclude those who are 
less proficient in English, they also may have resulted in prevalence 
underestimates. In one study, most of the respondents did not know 
the English name for over 90% of the herbal products in the study [21]. 
Regional studies, even those with probability sampling, reported much 
higher prevalence estimates than national studies. The differentials are 
likely to be due to a combination of factors, including non-response 
bias in the convenience samples and exclusion of botanicals common 
among Hispanics/Latinos in the national samples. 
Hispanic/Latino patient’s rates of disclosure of botanical 
supplement use to physicians are low [21]. In the general population, 
a third to half of supplement users discloses their use to health care 
providers [55,56]. Despite an expectation that disclosure rates would 
be substantially lower among Hispanics/Latinos, due to language and 
access challenges [40], in the studies reported in this review, disclosure 
levels among Hispanics/Latinos (median 30%) were only slightly 
lower than those reported in previous studies. Across studies, >60% 
of individuals reported that they do not tell their health care provider 
about taking botanical supplements. Moreover, in a chart review, only 
15% of botanical supplement use was documented in the medical 
record [13]. The lack of disclosure could put individuals at risk of 
adverse events related to botanical supplements or their interactions 
with prescription medications. 
Our finding that disclosure rates were higher for studies targeting, 
and asking about disclosure of any complementary therapy as compared 
with botanical supplement studies suggests that individuals are even 
less likely to disclose use of botanicals than other complementary 
therapies. This finding merits further investigation as it has important 
implications for both clinical practice and public health assessments.
Taken together, these findings suggest that botanical use among 
Hispanics/Latinos is underestimated both in the biomedical literature 
and by healthcare providers. Botanical use is often a cultural practice 
[40], occupying a space outside the biomedical milieu. Accurate 
assessment of botanical use depends on careful inquiries about the use of 
not only dietary supplements, herbal products, and home remedies, in 
Spanish where appropriate, but also about special foods and teas as well 
as personal and family health practices. Anecdotally, Hispanics/Latinos 
may not think of herbal teas as herbal remedies or therapies, even when 
specifically taken for treatment of a minor illness (e.g. mint for upset 
stomach, linden for nervousness/insomnia, aloe for constipation) or 
for prevention of disease (nopal for diabetes prevention). 
Limitations
This systematic review is limited in important ways. Variability in 
outcome definitions and recall periods make cross-study comparisons 
difficult—reported median prevalence estimates should be considered 
approximations. Biases, as described earlier, may also have enormous 
impacts on estimates. Moreover, available studies have insufficient 
information to determine if variations in prevalence are associated with 
differences in Hispanic/Latino background; for example, individuals 
from Puerto Rico may have very different use patterns than those from 
Mexico. 
Although we made every effort to retrieve all studies reporting 
prevalence of botanical supplements among Hispanics/Latinos in the 
biomedical literature, we may have missed those not listed within 
the databases we searched. In addition, studies not published in the 
literature would be excluded.
Conclusions
Despite the limitations, this systematic review provides a unique, 
comprehensive examination of botanical supplement prevalence among 
Hispanics/Latinos, using all available data. Although the prevalence 
estimates are highly variable, clear patterns emerged. Of particular 
interest are the differences in prevalence associated with variables 
related to Hispanic/Latino ethnicity such as the proportion Hispanics/
Latinos in the sample and the inclusion of botanicals common in the 
population. Studies directed toward non-Hispanic/Latino samples with 
inquiries in English only and inquiries regarding botanicals common 
in the general population only, may undercount botanical supplement 
use among Hispanics/Latinos. Additional prevalence studies in large 
Hispanic/Latino populations, with adequate data on Hispanic/Latino 
background are needed to address lingering uncertainties.
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